Response to Crizotinib and Clinical Outcome in ALK-Rearranged Pulmonary Pleomorphic Carcinoma.

@article{Murakami2015ResponseTC,
  title={Response to Crizotinib and Clinical Outcome in ALK-Rearranged Pulmonary Pleomorphic Carcinoma.},
  author={Yasushi Murakami and Hideo Saka and Masahide Oki},
  journal={Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer},
  year={2015},
  volume={10 5},
  pages={e28-9}
}
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS